Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600135079) titled 'A Randomized, Double-blind Phase I Clinical Trial of SAL0896 Injection' on Oct. 23.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Beijing Jishuitan Hospital, Capital Medical University
Condition:
liver cirrhosis with ascites and hypoalbuminemia
Intervention:
Phase Ia trial single-dose cohort:Intravenous infusion of SAL0896 injection or placebo, single dose
Phase Ia trial: multiple-dose cohort:Intravenous infusion of SAL0896 injection or placebo, multiple dose
Recruitment Status: Not Recruiting
Phase: 1
Date of First Enrollment: 2026-11-01
Target Sample Size: Phase Ia trial ...